Although the prevalence of IPMN is low, ranging from 3 to 6% in the general population, the development of modern imaging and the increase in health awareness has increased its detection.[1,2] IPMN is characterized by duct dilation and excessive mucin secretion in the main duct (MD) and/or the branch duct (BD) of the pancreas. This evidence concerns the gene MUC5AC and pancreatic intraductal papillary-mucinous neoplasm.